The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients
about
Systemic lupus erythematosus: strategies to improve pregnancy outcomesPlasmapheresis and pregnancy outcome in patients with antiphospholipid syndromeSerum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome.Are posttranslational modifications of β2-glycoprotein I markers for thrombotic risk? Are they triggers of autoimmunity?Female mouse fetal loss mediated by maternal autoantibodyAnticoagulation in management of antiphospholipid antibody syndrome in pregnancy.Tracing the molecular pathogenesis of antiphospholipid syndrome.Excess female siblings and male fetal loss in families with systemic lupus erythematosus.New developments in lupus-associated antiphospholipid syndrome.Complement activation and pregnancy failure.The clinical significance of coagulation and the inflammatory response in autoimmunity.Pregnancy and antiphospholipid syndrome.Emerging Therapies in Antiphospholipid Syndrome.PROMISSE: progress in understanding pregnancy complications in patients with SLE.Profiling the enzymatic properties and inhibition of human complement factor B.Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.Antiphospholipid Antibodies Inhibit Trophoblast Toll-like Receptor and Inflammasome Negative Regulators.Obstetric antiphospholipid syndrome
P2860
Q26741149-CEC19509-B71D-4CD9-AA2C-E4AB66FC811BQ28222227-C0FD1EAF-99D0-4848-9564-ECB87BDE9E2EQ33604935-B09B3496-79E7-49C6-817F-2375078CC088Q35224238-941CEEAB-AD3B-453D-A5CD-51D7630FFBA6Q36021796-F43FB1C9-7917-47E1-A4A9-360110AC1368Q36879113-6C823EEA-C55E-46EF-A019-D7A50BD04CD5Q36890865-315FC7A3-A23E-4430-B64C-1DC851D9B6AEQ36957998-FD4EAE02-E81B-4EDF-80E0-1483E23B46A7Q37168035-E4870987-4E21-4C39-9E79-5A81122F5BCCQ37638376-32584F4B-53B7-447E-940C-2D27C74B09B3Q37827404-2FB63A93-1EC6-4DA8-AAFE-240CCB98F825Q38070831-9CB1F8DC-CBF2-465F-A112-37D7DEEE475BQ38782057-F9C2198A-A484-4A23-8C35-CB07A9461156Q45750632-47123FDF-98E4-4C4C-8070-4A5A7A2A6108Q46962394-E446AA18-2BC7-4403-8A29-95214DD2AFA8Q47407572-766E6204-36C2-490A-BCA1-302EB2CCD20DQ49998565-15D0705F-DE3C-49FC-A97B-0B9BDC96DB44Q58551653-4890B85F-42CC-4AD7-88A8-6FD2B74E01B5
P2860
The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The antiphospholipid syndrome ...... e therapy of pregnant patients
@ast
The antiphospholipid syndrome ...... e therapy of pregnant patients
@en
The antiphospholipid syndrome ...... e therapy of pregnant patients
@nl
type
label
The antiphospholipid syndrome ...... e therapy of pregnant patients
@ast
The antiphospholipid syndrome ...... e therapy of pregnant patients
@en
The antiphospholipid syndrome ...... e therapy of pregnant patients
@nl
prefLabel
The antiphospholipid syndrome ...... e therapy of pregnant patients
@ast
The antiphospholipid syndrome ...... e therapy of pregnant patients
@en
The antiphospholipid syndrome ...... e therapy of pregnant patients
@nl
P2860
P3181
P356
P1476
The antiphospholipid syndrome ...... e therapy of pregnant patients
@en
P2093
Jane E Salmon
P2860
P304
140-7; quiz 1 p following 187
P3181
P356
10.1038/NCPRHEUM0432
P407
P577
2007-03-01T00:00:00Z